The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Confirmed three-year RFS and OS of the randomized trial of adjuvant S-1 versus S-1 plus docetaxel after curative resection of pStage III gastric cancer (JACCRO GC-07).
 
Kazuhiro Yoshida
Honoraria - Asahi Kasei; AstraZeneca; Bristol-Myers Squibb Japan; Chugai Pharma; Covidien; Daiichi Sankyo; Denka Co., Ltd; EA Pharma; Eisai; Johnson & Johnson; Lilly Japan; Merck Serono; MSD K.K; Nippon Kayaku; Novartis; Olympus; Ono Pharmaceutical; Otsuka; Pfizer; Sanofi; Sanwa Kagaku Kenkyusho; SBI Pharmaceuticals; Taiho Pharmaceutical; Takeda; Teijin Pharma; TERUMO; Tsumura & Co.; Yakult Honsha
Research Funding - Abbott (Inst); Abbvie (Inst); Asahi Kasei (Inst); Astellas Pharma (Inst); Biogen (Inst); Celgene (Inst); Chugai Pharma (Inst); Covidien (Inst); Daiichi Sankyo (Inst); Eisai (Inst); GlaxoSmithKline K.K. (Inst); Johnson & Johnson (Inst); Kaken Pharmaceutical (Inst); KCI (Inst); Koninklijke philips (Inst); Kyowa Hakko Kirin (Inst); Lilly Japan (Inst); Meiji Seika Kaisha (Inst); Merck Serono (Inst); MSD K.K (Inst); Nippon Kayaku (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Otsuka (Inst); Sanofi/Aventis (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Toray Industries (Inst); Tsumura & Co. (Inst); Yakult Honsha (Inst)
 
Yasuhiro Kodera
Honoraria - Chugai Pharma; Covidien/Medtronic; Daiichi Sankyo; Intuitive Surgical; Johnson & Johnson; Kaken Pharmaceutical; Lilly; MSD K.K; Nippon Kayaku; Ono Pharmaceutical; Otsuka; Taiho Pharmaceutical; Tsumura & Co.; Yakult Honsha
Research Funding - abbott Japan (Inst); Abbvie (Inst); Chugai Pharma (Inst); Covidien (Inst); Daiichi Sankyo (Inst); EA Pharma (Inst); Kaken Pharmaceutical (Inst); Lilly Japan (Inst); Maruho (Inst); Merck (Inst); MSD (Inst); Nippon Kayaku (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Otsuka (Inst); Otsuka (Inst); Pfizer (Inst); Sanofi (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Tsumura & Co. (Inst); Yakult Pharmaceutical (Inst)
 
Mitsugu Kochi
No Relationships to Disclose
 
Takeshi Sano
Speakers' Bureau - Johnson & Johnson; Medtronic; Ono Pharmaceutical; Taiho Pharmaceutical
 
Yoshihiro Kakeji
Honoraria - Chugai Pharma; Lilly; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Tsumura & Co.
Research Funding - Chugai Pharma (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Honsha (Inst)
 
Wataru Ichikawa
Honoraria - Bayer Yakuhin; Chugai Pharma; Daiichi Sankyo; Lilly Japan; Merck Serono; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Daiichi Sankyo
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo; Merck Serono (Inst); Ono Pharmaceutical (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Shintaro Kurahashi
No Relationships to Disclose
 
Hironori Yamaguchi
Honoraria - Chugai Pharma; Lilly Japan; Nippon Kayaku; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Chugai Pharma; Lilly Japan; Nippon Kayaku; Ono Pharmaceutical; Taiho Pharmaceutical
 
Takahiro Toyokawa
No Relationships to Disclose
 
Masato Nakamura
Honoraria - Bayer; Chugai Pharma; Lilly; Merck; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Kazumasa Fujitani
No Relationships to Disclose
 
Yoshinari Mochizuki
No Relationships to Disclose
 
Mitsuhiko Ota
No Relationships to Disclose
 
Jun Hihara
No Relationships to Disclose
 
Yoichi Makari
No Relationships to Disclose
 
Atsushi Takeno
No Relationships to Disclose
 
Masahiro Takeuchi
Consulting or Advisory Role - Hisamitsu Pharmaceutical; kyorindai; Taiho Pharmaceutical
 
Masashi Fujii
Travel, Accommodations, Expenses - Japan Clinical Cancer Research Organization; Taiho Pharmaceutical